NeuPath Health (TSXV:NPTH) 3-Year EBITDA Growth Rate : 0.00% (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is NeuPath Health 3-Year EBITDA Growth Rate?

NeuPath Health's EBITDA per Share for the three months ended in Jun. 2024 was C$0.02.

During the past 12 months, NeuPath Health's average EBITDA Per Share Growth Rate was 842.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of NeuPath Health was 31.40% per year. The lowest was 31.40% per year. And the median was 31.40% per year.

Competitive Comparison of NeuPath Health's 3-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, NeuPath Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeuPath Health's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NeuPath Health's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where NeuPath Health's 3-Year EBITDA Growth Rate falls into.

NeuPath Health 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

NeuPath Health (TSXV:NPTH) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

NeuPath Health 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of NeuPath Health's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

NeuPath Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NeuPath Health Inc (TSXV:NPTH) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

181 Bay Street, Suite 2100, Toronto, ON, CAN, M5J 2T3

Website

https://www.neupath.com

NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.

Executives

Grant Connelly	Senior Officer
Stephen Lemieux	Senior Officer

NeuPath Health Headlines

No Headlines